Netherlands· NL-0102fa30db10
Gelsemium-Homaccord
A medicinal product containing cimicifuga racemosa + cimicifuga racemosa + cimicifuga racemosa + cimicifuga racemosa, registered in Netherlands by Heel Belgium n.v..
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CIMICIFUGA RACEMOSA + CIMICIFUGA RACEMOSA + CIMICIFUGA RACEMOSA + CIMICIFUGA RACEMOSA
- Manufacturer
- Heel Belgium n.v.
- Country
- Netherlands (NL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id83415
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cimicifuga racemosa + cimicifuga racemosa + cimicifuga racemosa + cimicifuga racemosa in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBestmade Natural Products Cimicifuga RacemosaBestmade Natural Products
- PolandKlimadynonInPharm Sp. z o.o.
- FinlandCimicifuga
- CzechiaMENOFEMBionorica SE, Neumarkt
- SpainMENSIFEM COMPRIMIDOS RECUBIERTOS CON PELICULABionorica Se
- FranceMENSIFEM, comprimé pelliculéBIONORICA (ALLEMAGNE)
- NorwayRemifeminSchaper & Brümmer GmbH & Co KG
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Belgium · Donnafyta Meno
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa265d40-9b0a-460b-8b3f-bda27319c7ec GET /v1/drugs/aa265d40-9b0a-460b-8b3f-bda27319c7ec?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Druppels voor oraal gebruik, oplossing",
"route": "Oraal gebruik",
"soort": "RVH",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h83415_smpc.pdf",
"strength": null,
"atc_label": null,
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg83415",
"excipients": null,
"substances": [
"CIMICIFUGA RACEMOSA",
"CIMICIFUGA RACEMOSA",
"CIMICIFUGA RACEMOSA",
"CIMICIFUGA RACEMOSA",
"GELSEMIUM SEMPERVIRENS",
"GELSEMIUM SEMPERVIRENS",
"GELSEMIUM SEMPERVIRENS",
"GELSEMIUM SEMPERVIRENS",
"RHUS TOXICODENDRON",
"RHUS TOXICODENDRON",
"RHUS TOXICODENDRON",
"RHUS TOXICODENDRON"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h83415.pdf",
"authorised_at": "2010/11/15",
"procedure_number": null,
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "83415",
"additional_monitoring": "N"
}See everything about cimicifuga racemosa + cimicifuga racemosa + cimicifuga racemosa + cimicifuga racemosa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.